+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cattle & Porcine/Swine Reproductive Diseases Market by Disease Type (Bacterial Infections, Fungal Infections, Parasitic Infestations), Animal Type (Cattle, Swine), Diagnosis Type, Treatment Type, Prevention And Control, End-User - Global Forecast 2025-2030- Product Image
Cattle & Porcine/Swine Reproductive Diseases Market by Disease Type (Bacterial Infections, Fungal Infections, Parasitic Infestations), Animal Type (Cattle, Swine), Diagnosis Type, Treatment Type, Prevention And Control, End-User - Global Forecast 2025-2030- Product Image
Sale

Cattle & Porcine/Swine Reproductive Diseases Market by Disease Type (Bacterial Infections, Fungal Infections, Parasitic Infestations), Animal Type (Cattle, Swine), Diagnosis Type, Treatment Type, Prevention And Control, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055575
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cattle & Porcine/Swine Reproductive Diseases Market grew from USD 779.72 million in 2024 to USD 819.33 million in 2025. It is expected to continue growing at a CAGR of 5.29%, reaching USD 1.06 billion by 2030.

In an era marked by rapid advancements and evolving challenges in livestock health, the reproductive diseases affecting cattle and swine have come under intense scrutiny. This report sets the stage by highlighting the current state of the industry, characterized by diagnostic innovations, emerging treatment protocols, and preventive strategies that address a spectrum of pathogens. The introduction explores the critical need for detailed, data-driven analyses that underscore the interplay between disease dynamics and the socio-economic factors impacting farm productivity and animal welfare. It also emphasizes the complex nature of disease management, where bacterial, fungal, parasitic, and viral agents play multifaceted roles in shaping health outcomes. The comprehensive examination draws on recent clinical studies, market performance metrics, and evolving biosecurity practices, which collectively form the backbone of strategic insights for stakeholders. Amid an environment where disease management protocols are continuously evolving, the report navigates through emerging trends, regulatory frameworks, and competitive landscapes. With research that examines patterns across multiple dimensions - from disease type to diagnostic methodologies - readers are provided with a detailed roadmap that not only clarifies the magnitude of the challenges but also illuminates actionable paths for growth and innovation.

Transformative Shifts in the Livestock Health Landscape

The landscape of cattle and swine reproductive health has experienced transformative shifts in recent years, driven by technological innovations and a deeper understanding of pathogen interactions. Evolving diagnostic techniques, such as molecular approaches and advanced imaging, have revolutionized disease detection, enabling early intervention and thereby mitigating spread within herds. At the same time, the integration of novel treatment therapies, including targeted pharmaceuticals and strategic vaccinations, has redefined the way practitioners approach care and prevention. In addition, the emphasis on alternative treatments and biosecurity measures deepens the commitment to animal welfare and long-term disease prevention strategies. Economic and regulatory factors have further encouraged a paradigm shift; stakeholders are increasingly investing in sophisticated diagnostic tools that reduce downtime and improve overall animal well-being. Collaborative efforts between research institutions, veterinary clinics, and farms have fostered a conducive environment for replacing traditional practices with data-backed, technologically advanced solutions. This transformation is not just about adopting new tools - it signifies a broader reorientation towards sustainability, precision, and strategic response mechanisms that are influencing every level of the market.

Key Segmentation Insights in Reproductive Disease Management

A deep dive into market segmentation reveals critical insights pivotal to understanding how various factors interact within the realm of reproductive diseases. Deliberations surrounding disease type examine infectious agents where bacterial infections such as brucellosis, leptospirosis, and tuberculosis are scrutinized alongside critical fungal infections like dermatophytosis and mycotoxicosis. Parasitic infestations, represented by challenges such as coccidiosis, toxoplasmosis, and trichinosis, form another essential component of the overall picture, while the complexity of viral infections including conditions like foot and mouth disease, porcine reproductive and respiratory syndrome, and swine fever is rigorously evaluated. Analysis then shifts to categorizing diseases based on animal type, where the health dynamics of cattle - whether beef or dairy - and swine, from breeding swine to finishing pigs and nursery pigs, are methodically distinguished. The segmentation extends further into diagnostic types; methodologies are differentiated by applications such as culturing techniques including bacterial culture and viral isolation, diagnostic imaging comprised of ultrasonography and x-ray imaging, as well as molecular methods like LAMP assays and PCR, and serological tests that encompass AGID, ELISA, and SNT. Moreover, treatment strategies are examined through the lens of alternative therapies featuring herbal treatments and homoeopathy, pharmaceuticals that include antibiotics, antiparasitics, and antivirals, surgical interventions that range from corrective to prophylactic surgeries, and an array of vaccination strategies involving both inactivated and live attenuated vaccines. Supplementing these perspectives are preventive measures that engage biosecurity practices such as disinfection and quarantine protocols, breeding management through techniques like artificial insemination and genetic selection, hygiene management with sanitation and waste protocols, and nutritional management that emphasizes balanced diet plans and organic feed options. Lastly, the market’s end-users, from farms to research institutions and veterinary clinics, complete the segmentation analysis and offer a comprehensive view of the various stakeholders. This detailed breakdown not only enhances our understanding of the market’s diversity but also provides insights that facilitate targeted strategies and innovation.

Based on Disease Type, market is studied across Bacterial Infections, Fungal Infections, Parasitic Infestations, and Viral Infections. The Bacterial Infections is further studied across Brucellosis, Leptospirosis, and Tuberculosis. The Fungal Infections is further studied across Dermatophytosis and Mycotoxicosis. The Parasitic Infestations is further studied across Coccidiosis, Toxoplasmosis, and Trichinosis. The Viral Infections is further studied across Foot And Mouth Disease, Porcine Reproductive And Respiratory Syndrome (PRRS), and Swine Fever.

Based on Animal Type, market is studied across Cattle and Swine. The Cattle is further studied across Beef Cattle and Dairy Cattle. The Swine is further studied across Breeding Swine, Finishing Pigs, and Nursery Pigs.

Based on Diagnosis Type, market is studied across Culturing Techniques, Diagnostic Imaging, Molecular Methods, and Serological Tests. The Culturing Techniques is further studied across Bacterial Culture and Viral Isolation. The Diagnostic Imaging is further studied across Ultrasonography and X-Ray Imaging. The Molecular Methods is further studied across LAMP Assays and PCR. The Serological Tests is further studied across AGID, ELISA, and SNT.

Based on Treatment Type, market is studied across Alternative Therapies, Pharmaceuticals, Surgical Interventions, and Vaccinations. The Alternative Therapies is further studied across Herbal Treatments and Homoeopathy. The Pharmaceuticals is further studied across Antibiotics, Antiparasitics, and Antivirals. The Surgical Interventions is further studied across Corrective Surgeries and Prophylactic Surgeries. The Vaccinations is further studied across Inactivated Vaccines and Live Attenuated Vaccines.

Based on Prevention And Control, market is studied across Biosecurity Measures, Breeding Management, Hygiene Management, and Nutritional Management. The Biosecurity Measures is further studied across Disinfection Practices and Quarantine Protocols. The Breeding Management is further studied across Artificial Insemination Techniques and Genetic Selection Programs. The Hygiene Management is further studied across Sanitation Protocols and Waste Management. The Nutritional Management is further studied across Balanced Diet Plans and Organic Feed Options.

Based on End-User, market is studied across Farms, Research Institutions, and Veterinary Clinics.

Key Regional Insights Impacting Livestock Health

Dissecting regional dynamics gives way to nuanced insights into how reproductive disease trends manifest across different areas of the globe. In the Americas, the market is characterized by robust investments in innovative livestock health solutions and a strong adoption of sophisticated diagnostic technologies, reflecting a high level of regulatory oversight. Transitioning to Europe, the Middle East and Africa, we see an interplay of stringent biosecurity measures, advanced therapeutic protocols, and an emphasis on sustainable practices that collectively aim to reduce disease prevalence. The Asia-Pacific region, in contrast, presents a burgeoning landscape where rapid industrialization and a growing focus on modern farming methods have spurred significant advancements in disease prevention and management. These regional distinctions offer a broader perspective on how economic, cultural, and infrastructural factors shape the approach to managing reproductive diseases in cattle and swine, underscoring the importance of a tailored strategy that addresses unique local challenges.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation in Reproductive Disease Solutions

Strategic market analysis is further enriched by insights drawn from key industry players who are defining the competitive landscape. Leaders such as Anicon Labor GmbH, Biogenesis Bago SA, and Biomin Holding GmbH are spearheading innovation through integrated research and technology-driven solutions. Global entities including Boehringer Ingelheim Animal Health and CEVA Santé Animale carry significant weight in shaping industry trends with their diverse portfolios, while the expertise of Dechra Pharmaceuticals PLC and Eco Animal Health Group plc is instrumental in advancing therapeutic regimens. Companies like Elanco Animal Health Incorporated, Hipra, and organizations under the umbrella of Huvepharma EOOD and Huvepharma Inc. have made remarkable strides in vaccine development and disease control. Contributions from IDEXX Laboratories, Inc., Innovacyn, Inc., and Kaneka Corporation through its subsidiary further highlight the drive for precision diagnostics and advanced treatment modalities. This is complemented by the efforts of Medovent GmbH, Merck Animal Health, and MSD Animal Health that continually push the boundaries in pharmaceutical research. Additionally, prominent roles are played by Neogen Corporation, Norbrook Laboratories Ltd., Vetoquinol Global, Virbac S.A., and Zoetis Inc. The synthesis of these insights offers a window into the strategies driving product innovations and market expansions, ultimately crafting a competitive environment where research and development are central to future successes.

The report delves into recent significant developments in the Cattle & Porcine/Swine Reproductive Diseases Market, highlighting leading vendors and their innovative profiles. These include Anicon Labor GmbH, Biogenesis Bago SA, Biomin Holding GmbH, Boehringer Ingelheim Animal Health, CEVA Santé Animale, Dechra Pharmaceuticals PLC, Eco Animal Health Group plc, Elanco Animal Health Incorporated, Hipra, Huvepharma EOOD, Huvepharma Inc., IDEXX Laboratories, Inc., Innovacyn, Inc., Kaneka Corporation (via subsidiary), Medovent GmbH, Merck Animal Health, MSD Animal Health, Neogen Corporation, Norbrook Laboratories Ltd., Vetoquinol Global, Virbac S.A., and Zoetis Inc..

Actionable Recommendations for Industry Leaders

For industry leaders seeking to sustain growth and remain competitive, it is crucial to prioritize integrated solutions that blend state-of-the-art diagnostic methodologies with proactive treatment regimens. Investment in research and development should be accelerated to further refine molecular), serological, and imaging technologies, ensuring that practitioners can detect diseases at earlier stages. Leaders should also consider fostering strategic alliances with diagnostic labs and research institutions to share insights and enhance operational efficiency. Embracing cutting-edge therapeutic approaches - ranging from precision pharmaceuticals to innovative vaccine formulations - will be key to addressing the dynamic challenges posed by bacterial, fungal, viral, and parasitic infections. To optimize operational efficiency, routine assessments of breeding and nutritional management systems should be conducted, aligning them with the latest biosecurity protocols. The recommendations stress a balanced approach between proactive prevention strategies and responsive treatment measures, ensuring that resources are allocated effectively in a landscape that is in constant flux.

Charting the Future of Livestock Disease Management

In summary, the in-depth assessment provides a roadmap for understanding the complex interplay between disease dynamics and market segmentation in cattle and swine reproductive health. The report articulates the critical need for evolving diagnostic and therapeutic strategies that are responsive to regional, technological, and operational shifts. By integrating the latest advancements in clinical research with varied strategic imperatives, the insights presented here help delineate a clear path forward for addressing both existing challenges and emerging opportunities. The consolidation of scientific rigor, technological innovation, and strategic market analysis offers stakeholders a detailed vision that underscores the urgency of adopting modern practices to safeguard livestock health and enhance biosecurity. Ultimately, the evolution of this market speaks to a broader imperative for continuous improvement and cross-sector collaboration in achieving long-term success.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing global demand for meat and dairy products is driving the need for effective disease management
5.1.1.2. Rising in biosecurity measures focus on preventing the spread of infectious diseases in livestock populations
5.1.1.3. Growing awareness among farmers enhancing the adoption of effective disease prevention methods
5.1.2. Restraints
5.1.2.1. High cost of veterinary services and treatments for reproductive diseases
5.1.3. Opportunities
5.1.3.1. Ongoing partnerships between pharmaceutical companies and agricultural sectors enhancing disease control solutions
5.1.3.2. Enhancing diagnostics through AI-driven tools to provide rapid results for cattle and porcine health issues
5.1.4. Challenges
5.1.4.1. Limited access to veterinary services in rural areas restricts effective disease management
5.2. Market Segmentation Analysis
5.2.1. End-User: Ongoing advancement of cattle & swine reproductive health in research institutions
5.2.2. Disease Type: Growing research on the impact of Brucellosis, Leptospirosis, and Tuberculosis on Cattle & Porcine Reproductive Diseases
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cattle & Porcine/Swine Reproductive Diseases Market, by Disease Type
6.1. Introduction
6.2. Bacterial Infections
6.2.1. Brucellosis
6.2.2. Leptospirosis
6.2.3. Tuberculosis
6.3. Fungal Infections
6.3.1. Dermatophytosis
6.3.2. Mycotoxicosis
6.4. Parasitic Infestations
6.4.1. Coccidiosis
6.4.2. Toxoplasmosis
6.4.3. Trichinosis
6.5. Viral Infections
6.5.1. Foot And Mouth Disease
6.5.2. Porcine Reproductive And Respiratory Syndrome (PRRS)
6.5.3. Swine Fever
7. Cattle & Porcine/Swine Reproductive Diseases Market, by Animal Type
7.1. Introduction
7.2. Cattle
7.2.1. Beef Cattle
7.2.2. Dairy Cattle
7.3. Swine
7.3.1. Breeding Swine
7.3.2. Finishing Pigs
7.3.3. Nursery Pigs
8. Cattle & Porcine/Swine Reproductive Diseases Market, by Diagnosis Type
8.1. Introduction
8.2. Culturing Techniques
8.2.1. Bacterial Culture
8.2.2. Viral Isolation
8.3. Diagnostic Imaging
8.3.1. Ultrasonography
8.3.2. X-Ray Imaging
8.4. Molecular Methods
8.4.1. LAMP Assays
8.4.2. PCR
8.5. Serological Tests
8.5.1. AGID
8.5.2. ELISA
8.5.3. SNT
9. Cattle & Porcine/Swine Reproductive Diseases Market, by Treatment Type
9.1. Introduction
9.2. Alternative Therapies
9.2.1. Herbal Treatments
9.2.2. Homoeopathy
9.3. Pharmaceuticals
9.3.1. Antibiotics
9.3.2. Antiparasitics
9.3.3. Antivirals
9.4. Surgical Interventions
9.4.1. Corrective Surgeries
9.4.2. Prophylactic Surgeries
9.5. Vaccinations
9.5.1. Inactivated Vaccines
9.5.2. Live Attenuated Vaccines
10. Cattle & Porcine/Swine Reproductive Diseases Market, by Prevention And Control
10.1. Introduction
10.2. Biosecurity Measures
10.2.1. Disinfection Practices
10.2.2. Quarantine Protocols
10.3. Breeding Management
10.3.1. Artificial Insemination Techniques
10.3.2. Genetic Selection Programs
10.4. Hygiene Management
10.4.1. Sanitation Protocols
10.4.2. Waste Management
10.5. Nutritional Management
10.5.1. Balanced Diet Plans
10.5.2. Organic Feed Options
11. Cattle & Porcine/Swine Reproductive Diseases Market, by End-User
11.1. Introduction
11.2. Farms
11.3. Research Institutions
11.4. Veterinary Clinics
12. Americas Cattle & Porcine/Swine Reproductive Diseases Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Cattle & Porcine/Swine Reproductive Diseases Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Scenario Analysis
15.3.1. Merck Animal Health launch SENSEHUB cow calf for enhanced breeding success
15.3.2. NutriQuest and Modulant Biosciences partner to innovate swine disease control
15.3.3. EpiVax and Zoetis collaborate to enhance swine vaccine effectiveness with CircoMatch tool
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET MULTI-CURRENCY
FIGURE 2. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET MULTI-LANGUAGE
FIGURE 3. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET RESEARCH PROCESS
FIGURE 4. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 15. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2024 VS 2030 (%)
FIGURE 17. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 19. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 23. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 29. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET DYNAMICS
TABLE 7. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BRUCELLOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY LEPTOSPIROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DERMATOPHYTOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MYCOTOXICOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COCCIDIOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TOXOPLASMOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TRICHINOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FOOT AND MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS), BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE FEVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FINISHING PIGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NURSERY PIGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL ISOLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ULTRASONOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY LAMP ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY AGID, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SNT, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HERBAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HOMOEOPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CORRECTIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PROPHYLACTIC SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISINFECTION PRACTICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY QUARANTINE PROTOCOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ARTIFICIAL INSEMINATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY GENETIC SELECTION PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SANITATION PROTOCOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY WASTE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BALANCED DIET PLANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ORGANIC FEED OPTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 168. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 169. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 170. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
TABLE 171. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 172. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 173. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 174. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
TABLE 175. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 176. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 177. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 178. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
TABLE 179. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 180. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 181. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 182. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 183. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 184. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
TABLE 185. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
TABLE 186. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
TABLE 187. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 188. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 189. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 190. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 192. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 193. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 194. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
TABLE 195. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 197. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 198. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
TABLE 199. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 200. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 201. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 202. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
TABLE 203. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 204. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 205. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 206. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 207. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 208. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
TABLE 209. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
TABLE 210. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
TABLE 211. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 212. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 213. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 214. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUN

Companies Mentioned

  • Anicon Labor GmbH
  • Biogenesis Bago SA
  • Biomin Holding GmbH
  • Boehringer Ingelheim Animal Health
  • CEVA Santé Animale
  • Dechra Pharmaceuticals PLC
  • Eco Animal Health Group plc
  • Elanco Animal Health Incorporated
  • Hipra
  • Huvepharma EOOD
  • Huvepharma Inc.
  • IDEXX Laboratories, Inc.
  • Innovacyn, Inc.
  • Kaneka Corporation (via subsidiary)
  • Medovent GmbH
  • Merck Animal Health
  • MSD Animal Health
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Vetoquinol Global
  • Virbac S.A.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 819.33 Million
Forecasted Market Value ( USD ) by 2030 $ 1060 Million
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Cattle & Porcine/Swine Reproductive Diseases Market by Product (Diagnostics (ELISA, PCR, Rapid Antigen Testing), Pharmaceuticals (Vaccines), Supplements, Animal Type, Disease (BVD, PRRS, Leptospirosis, Brucellosis), End User - Global Forecast to 2029 - Product Image

Cattle & Porcine/Swine Reproductive Diseases Market by Product (Diagnostics (ELISA, PCR, Rapid Antigen Testing), Pharmaceuticals (Vaccines), Supplements, Animal Type, Disease (BVD, PRRS, Leptospirosis, Brucellosis), End User - Global Forecast to 2029

  • Report
  • 334 Pages
  • Global
From
Swine Vaccines Market by Product, Type, Target Disease - Global Forecast 2025-2030 - Product Image

Swine Vaccines Market by Product, Type, Target Disease - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Veterinary Artificial Insemination Market Size, Share & Trends Analysis Report By Solutions (Equipment & Consumables, Semen, Services), By Animal Type, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Veterinary Artificial Insemination Market Size, Share & Trends Analysis Report By Solutions (Equipment & Consumables, Semen, Services), By Animal Type, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 160 Pages
  • Global
From
Livestock Insurance Market by Coverage Type, Animal Type, Distribution Channel, End User, Duration - Global Forecast 2025-2030 - Product Image

Livestock Insurance Market by Coverage Type, Animal Type, Distribution Channel, End User, Duration - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Animal Genetics Market Size, Share & Trends Analysis Report by Animal Type, Type (Assistive Reproduction Technologies, Live Animals, Genomic/ Genetic Testing), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Animal Genetics Market Size, Share & Trends Analysis Report by Animal Type, Type (Assistive Reproduction Technologies, Live Animals, Genomic/ Genetic Testing), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.